1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Transdermal Medical Patch Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Transdermal Medical Patch Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Prevalence of Chronic Diseases
- 5.1.2 Growing Consumption of Tobacco
5.2 Market Opportunities
- 5.2.1 Increasing Strategic Initiatives
5.3 Future Trends
- 5.3.1 Advancements in Smart Patches and Three- Dimensional (3D)-Printed Patches
5.4 Impact of Drivers and Restraints
6. Europe Transdermal Medical Patch Market Regional Analysis
6.1 Europe Transdermal Medical Patch Market Overview
6.2 Europe Transdermal Medical Patch Market Revenue 2021-2028 (US$ Million)
6.3 Europe Transdermal Medical Patch Market Forecast Analysis
7. Europe Transdermal Medical Patch Market Analysis – by Type
7.1 Single Layer Drug-in-Adhesive
- 7.1.1 Overview
- 7.1.2 Single Layer Drug-in-Adhesive: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Multi-layer Drug-in-Adhesive
- 7.2.1 Overview
- 7.2.2 Multi-layer Drug-in-Adhesive: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Reservoir
- 7.3.1 Overview
- 7.3.2 Reservoir: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Vapor Patch
- 7.4.1 Overview
- 7.4.2 Vapor Patch: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Matrix
- 7.5.1 Overview
- 7.5.2 Matrix: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Transdermal Medical Patch Market Analysis – by Application
8.1 Neurologic Conditions
- 8.1.1 Overview
- 8.1.2 Neurologic Conditions: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Pain Management
- 8.2.1 Overview
- 8.2.2 Pain Management: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Nicotine Cessation
- 8.3.1 Overview
- 8.3.2 Nicotine Cessation: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Cardiovascular Disorders
- 8.4.1 Overview
- 8.4.2 Cardiovascular Disorders: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Hormonal Therapy
- 8.5.1 Overview
- 8.5.2 Hormonal Therapy: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Transdermal Medical Patch Market Analysis – by Distribution Channel
9.1 Hospital Pharmacies
- 9.1.1 Overview
- 9.1.2 Hormonal Therapy: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Retail Pharmacies
- 9.2.1 Overview
- 9.2.2 Hormonal Therapy: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Online Pharmacies
- 9.3.1 Overview
- 9.3.2 Hormonal Therapy: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Transdermal Medical Patch Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Transdermal Medical Patch Market Breakdown, by Key
Country, 2024 and 2028 (%)
- 10.1.1.1 Europe Transdermal Medical Patch Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 UK: Europe Transdermal Medical Patch Market Breakdown, by Type
- 10.1.1.1.2 UK: Europe Transdermal Medical Patch Market Breakdown, by Application
- 10.1.1.1.3 UK: Europe Transdermal Medical Patch Market Breakdown, by Distribution Channel
- 10.1.1.2 Germany:
Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Germany: Europe Transdermal Medical Patch Market Breakdown, by Type
- 10.1.1.2.2 Germany: Europe Transdermal Medical Patch Market Breakdown, by Application
- 10.1.1.2.3 Germany: Europe Transdermal Medical Patch Market Breakdown, by Distribution Channel
- 10.1.1.3 France:
Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 France: Europe Transdermal Medical Patch Market Breakdown, by Type
- 10.1.1.3.2 France: Europe Transdermal Medical Patch Market Breakdown, by Application
- 10.1.1.3.3 France: Europe Transdermal Medical Patch Market Breakdown, by Distribution Channel
- 10.1.1.4 Russia:
Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Russia: Europe Transdermal Medical Patch Market Breakdown, by Type
- 10.1.1.4.2 Russia: Europe Transdermal Medical Patch Market Breakdown, by Application
- 10.1.1.4.3 Russia: Europe Transdermal Medical Patch Market Breakdown, by Distribution Channel
- 10.1.1.5 Italy:
Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.1 Italy: Europe Transdermal Medical Patch Market Breakdown, by Type
- 10.1.1.5.2 Italy: Europe Transdermal Medical Patch Market Breakdown, by Application
- 10.1.1.5.3 Italy: Europe Transdermal Medical Patch Market Breakdown, by Distribution Channel
- 10.1.1.6 Rest of Europe:
Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Transdermal Medical Patch Market Breakdown, by Type
- 10.1.1.6.2 Rest of Europe: Europe Transdermal Medical Patch Market Breakdown, by Application
- 10.1.1.6.3 Rest of Europe: Europe Transdermal Medical Patch Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Transdermal Medical Patch Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Hisamitsu Pharmaceutical Co Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Medline Industries LP
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Johnsons and Johnsons
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Novartis AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Teva Pharmaceutical Industries Ltd.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 UCB SA
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Viatris Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Endo International Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Boehringer Ingelheim International GmbH
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights